Technemab (Sorin Biomedica)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTechnemab (Sorin Biomedica)

Drug Alias NameTechnemab

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesSorin Biomedica Spa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSorin

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A